Ute Bauer

Bielefeld University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Harald Behrens

Leibniz University Hannover

Orkan Okan

Technical University of Munich

Jonathan B. Levitt

City College of New York

Klaus Obermayer

Technische Universität Berlin

Michael Scholz

Technische Universität Berlin

Jennifer S. Lund

University of Utah

Alexander Hemprich

Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie

Joachim Deubener

Clausthal University of Technology

Poramate Pitak‐Arnnop

Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie

Kittipong Dhanuthai

Chulalongkorn University

Cooperative Institutions

Universitäts Frauenklinik

183

University of Vienna

Universitätsklinik für Frauenheilkunde und Geburtshilfe

Ludwig-Maximilians-Universität München

Heidelberg University

Medical University of Vienna

Leipzig University

Klinik für Frauenheilkunde

Olgahospital

Charité - Universitätsmedizin Berlin

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Carboplatin, VP-16 beim epithelialen Ovarialkarzinom -erste Erfahrungen

Gyn�kologisch-geburtshilfliche Rundschau (1988)

N. Vavra P. Sevelda Ch. Dittrich Ute Bauer H. Sälzer

Carboplatin

10.1159/000270820

Cite

Citations (1)

Basic response properties in layer 4C of the primate striate cortex: Afferent and intracortical contributions.

Ute Bauer Michael Scholz Jonathan B. Levitt Jennifer S. Lund Klaus Obermayer

Source

Cite

Citations (0)

Optimizing Injectable Poly-L-Lactic Acid Administration for Soft Tissue Augmentation: The Rationale for Three Treatment Sessions

Canadian Journal of Plastic Surgery (2011)

Ute Bauer Miles Graivier

The availability and variety of different injectable modalities has led to a dramatic increase in soft tissue augmentation procedures in recent years. Injectable poly-L-lactic acid (PLLA) is a synthetic, biodegradable polymer device approved in the United States for use in immunocompetent patients as a single regimen of up to four treatment sessions for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. Injectable PLLA is also approved for restoration and/or correction of signs of facial fat loss (lipoatrophy) in individuals with HIV.The present article provides an overview of previous studies with injectable PLLA, and specifically focuses on the number of recommended treatment sessions and intervals between treatment sessions. The authors also provide two case studies to support their recommendations for an average of three treatment sessions.Although the specific mechanisms remain hypothetical, injections of PLLA are believed to cause a cascade of cellular events that lead to collagen repair and subsequent restoration of facial volume. Because the development of a response to injectable PLLA is gradual and its duration of effect is long lasting, sufficient time between treatment sessions should be allocated to avoid overcorrection.Studies of injectable PLLA support the hypothesized mode of operation, and the experience and clinical recommendations of the authors that suggest that three treatment sessions are an optimal regimen for use of injectable PLLA in the majority of patients.

Regimen

Modalities

10.1177/229255031101900311

Cite

Citations (15)

A novel quantification of blood–brain barrier damage and histochemical typing after embolic stroke in rats

Brain Research (2010)

Dominik Michalski Jens Grosche Johann Pelz Dietmar Schneider Christopher M. Weise

NeuN

Fluorescein isothiocyanate

10.1016/j.brainres.2010.08.045

Cite